Cell administration routes for heart failure: a comparative re-evaluation of the REGENERATE-DCM and REGENERATE-IHD trials. Supplementary tables

<strong>Table S1. Baseline characteristics of the REGENERATE-DCM and REGENERATE-IHD trials</strong>
<br>

<strong>Table S2. The characteristics of the cells found in the injectate in the individual trials.</strong>
<br>

<strong>Table S3. The pooled characteristics of the cells found in the peripheral blood and the injectate.</strong>
<br>

<strong>Table S4. Left ventricular ejection fraction and volumes</strong>
<br>

<strong>Table S5. Overview of randomised controlled cell therapy trials for heart failure divided by delivery route.</strong>